NO990722L - Fremgangsmåte for behandling av hjertesvikt - Google Patents

Fremgangsmåte for behandling av hjertesvikt

Info

Publication number: NO990722L
Authority: NO; Norway
Prior art keywords: heart failure; treatment; procedure; phenoxy; trimethyl
Prior art date: 1998-02-17

Application number

NO990722A

Other languages

English (en)

Norwegian (no)

Other versions

NO990722D0 (no

Inventor

Yuhpyng Liang Chen

Anthony Andrea Fossa

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-17

Filing date

1999-02-16

Publication date

1999-08-18

1999-02-16 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-02-16 Publication of NO990722D0 publication Critical patent/NO990722D0/no

1999-08-18 Publication of NO990722L publication Critical patent/NO990722L/no

Links

206010019280 Heart failures Diseases 0.000 title abstract 4
238000000034 method Methods 0.000 title abstract 3
-1 1-ethyl-propoxy Chemical group 0.000 abstract 2
206010007559 Cardiac failure congestive Diseases 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 2
VIZBSVDBNLAVAW-UHFFFAOYSA-N 3,6-dimethyl-n-pentan-3-yl-2-(2,4,6-trimethylphenoxy)pyridin-4-amine Chemical compound CCC(CC)NC1=CC(C)=NC(OC=2C(=CC(C)=CC=2C)C)=C1C VIZBSVDBNLAVAW-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO990722A 1998-02-17 1999-02-16 Fremgangsmåte for behandling av hjertesvikt NO990722L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7493498P	1998-02-17	1998-02-17

Publications (2)

Publication Number	Publication Date
NO990722D0 NO990722D0 (no)	1999-02-16
NO990722L true NO990722L (no)	1999-08-18

Family

ID=22122537

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO990722A NO990722L (no)	1998-02-17	1999-02-16	Fremgangsmåte for behandling av hjertesvikt

Country Status (28)

Country	Link
US (1)	US6043260A (fr)
EP (1)	EP0951906A1 (fr)
JP (1)	JPH11292766A (fr)
KR (1)	KR19990072616A (fr)
CN (1)	CN1231176A (fr)
AP (1)	AP9901464A0 (fr)
AR (1)	AR017723A1 (fr)
AU (1)	AU1732999A (fr)
BG (1)	BG103180A (fr)
BR (1)	BR9900653A (fr)
CA (1)	CA2262252C (fr)
EA (1)	EA199900124A3 (fr)
GT (1)	GT199900015A (fr)
HR (1)	HRP990054A2 (fr)
HU (1)	HUP9900386A3 (fr)
ID (1)	ID23218A (fr)
IL (1)	IL128531A0 (fr)
IS (1)	IS4975A (fr)
MA (1)	MA26608A1 (fr)
NO (1)	NO990722L (fr)
OA (1)	OA10976A (fr)
PA (1)	PA8467401A1 (fr)
PE (1)	PE20000266A1 (fr)
PL (1)	PL331507A1 (fr)
SG (1)	SG81261A1 (fr)
TN (1)	TNSN99024A1 (fr)
TR (1)	TR199900328A2 (fr)
ZA (1)	ZA991220B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6956047B1 (en)	1995-06-06	2005-10-18	Pfizer Inc.	Corticotropin releasing factor antagonists
US6403599B1 (en)	1995-11-08	2002-06-11	Pfizer Inc	Corticotropin releasing factor antagonists
US7067664B1 (en)	1995-06-06	2006-06-27	Pfizer Inc.	Corticotropin releasing factor antagonists
US6387894B1 (en) *	1999-06-11	2002-05-14	Pfizer Inc.	Use of CRF antagonists and renin-angiotensin system inhibitors
US6585995B1 (en) *	1999-09-21	2003-07-01	Hanson Stephen R	Methods and compositions for treating platelet-related disorders
HUP0204272A3 (en) *	2000-01-18	2005-03-29	Pfizer Prod Inc	Corticotropin releasing factor antagonists, pharmaceutical compositions containing them and their use
GB0027410D0 (en) *	2000-11-09	2000-12-27	Pfizer Ltd	Mutual prodrug of amlodipine and atorvastatin
US6737430B2 (en)	2000-11-09	2004-05-18	Pfizer, Inc.	Mutual prodrug of amlodipine and atorvastatin
US6992087B2 (en)	2001-11-21	2006-01-31	Pfizer Inc	Substituted aryl 1,4-pyrazine derivatives
MXPA04007026A (es)	2002-02-22	2004-10-11	Pharmacia & Up John Company	Pirimidinonas y pirimidintionas sustituidas.
EP1485384A1 (fr) *	2002-03-13	2004-12-15	Pharmacia & Upjohn Company LLC	Derives de pyrazolo(1,5-a)pyridine utilises en tant que modulateurs du neurotransmetteur
JP2005533014A (ja) *	2002-04-26	2005-11-04	ファルマシア・アンド・アップジョン・カンパニー・エルエルシー	置換ピラジン誘導体
US20040116444A1 (en) *	2002-09-12	2004-06-17	Corbett Jeffrey W.	Substituted 1,4-pyrazine derivatives
AR041470A1 (es) *	2002-10-17	2005-05-18	Upjohn Co	Compuestos de pirrolo (1,2 - b) piridazina y sus usos
EP1565454A1 (fr) *	2002-11-21	2005-08-24	Pharmacia & Upjohn Company LLC	Composes de pyrazine en tant que modulateurs de crf
BRPI0409649A (pt) *	2003-04-23	2006-04-25	Pharmacia & Upjohn Co Llc	pirimidinonas e pirimidinotionas substituìdas como antagonistas de crf
CA2523072A1 (fr) *	2003-05-07	2004-11-18	Pharmacia & Upjohn Company Llc	Composes pyrrolo[1,2-b]pyridaziniques
JP2006525993A (ja) *	2003-05-09	2006-11-16	ファルマシア・アンド・アップジョン・カンパニー・エルエルシー	Ｃｒｆ１受容体拮抗剤である化合物
MXPA05012081A (es) *	2003-05-09	2006-02-22	Pharmacia & Upjohn Co Llc	Derivados de pirimidina sustituidos.
CA2525195A1 (fr) *	2003-05-09	2004-11-18	Pharmacia & Upjohn Company Llc	Pyrazinones a titre d'antagonistes du recepteur de crf1 dans le traitement des troubles du systeme nerveux central
WO2005089639A2 (fr) *	2004-03-16	2005-09-29	Talarico M D Matthew T	Procede de deregulation vasculaire
US20060211710A1 (en) *	2005-03-17	2006-09-21	Pfizer Inc	Substituted aryl 1,4-pyrazine derivatives
US8338441B2 (en) *	2009-05-15	2012-12-25	Gilead Sciences, Inc.	Inhibitors of human immunodeficiency virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW530047B (en) *	1994-06-08	2003-05-01	Pfizer	Corticotropin releasing factor antagonists
US6403599B1 (en) *	1995-11-08	2002-06-11	Pfizer Inc	Corticotropin releasing factor antagonists
EP0795327A1 (fr) *	1996-03-13	1997-09-17	Pfizer Inc.	Utilisation de l'amlodipine pour le traitement et la prophylaxie de l'insuffisance cardiaque congestive d'origine non-ischémique

1999
- 1999-01-18 PA PA19998467401A patent/PA8467401A1/es unknown
- 1999-02-02 GT GT199900015A patent/GT199900015A/es unknown
- 1999-02-10 US US09/248,073 patent/US6043260A/en not_active Expired - Fee Related
- 1999-02-10 SG SG9900526A patent/SG81261A1/en unknown
- 1999-02-11 AP APAP/P/1999/001464A patent/AP9901464A0/en unknown
- 1999-02-11 CN CN99102122A patent/CN1231176A/zh active Pending
- 1999-02-11 IS IS4975A patent/IS4975A/is unknown
- 1999-02-11 EP EP99301006A patent/EP0951906A1/fr not_active Withdrawn
- 1999-02-12 PE PE1999000127A patent/PE20000266A1/es not_active Application Discontinuation
- 1999-02-12 KR KR1019990004934A patent/KR19990072616A/ko not_active Ceased
- 1999-02-12 BR BR9900653-7A patent/BR9900653A/pt not_active Application Discontinuation
- 1999-02-15 IL IL12853199A patent/IL128531A0/xx unknown
- 1999-02-15 ID IDP990113D patent/ID23218A/id unknown
- 1999-02-15 CA CA002262252A patent/CA2262252C/fr not_active Expired - Fee Related
- 1999-02-16 TR TR1999/00328A patent/TR199900328A2/xx unknown
- 1999-02-16 BG BG103180A patent/BG103180A/bg unknown
- 1999-02-16 JP JP11037464A patent/JPH11292766A/ja active Pending
- 1999-02-16 EA EA199900124A patent/EA199900124A3/ru unknown
- 1999-02-16 AU AU17329/99A patent/AU1732999A/en not_active Abandoned
- 1999-02-16 AR ARP990100619A patent/AR017723A1/es unknown
- 1999-02-16 MA MA25465A patent/MA26608A1/fr unknown
- 1999-02-16 HU HU9900386A patent/HUP9900386A3/hu unknown
- 1999-02-16 TN TNTNSN99024A patent/TNSN99024A1/fr unknown
- 1999-02-16 ZA ZA9901220A patent/ZA991220B/xx unknown
- 1999-02-16 OA OA9900034A patent/OA10976A/en unknown
- 1999-02-16 NO NO990722A patent/NO990722L/no unknown
- 1999-02-17 PL PL99331507A patent/PL331507A1/xx unknown
- 1999-02-17 HR HR60/074,934A patent/HRP990054A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
MA26608A1 (fr)	2004-12-20
NO990722D0 (no)	1999-02-16
HRP990054A2 (en)	2000-02-29
PE20000266A1 (es)	2000-04-07
CA2262252A1 (fr)	1999-08-17
HU9900386D0 (en)	1999-04-28
EA199900124A2 (ru)	1999-08-26
HUP9900386A2 (hu)	1999-11-29
BR9900653A (pt)	2000-10-17
PL331507A1 (en)	1999-08-30
PA8467401A1 (es)	2000-09-29
IL128531A0 (en)	2000-01-31
BG103180A (bg)	1999-09-30
US6043260A (en)	2000-03-28
OA10976A (en)	2001-11-05
GT199900015A (es)	2000-07-26
EA199900124A3 (ru)	1999-12-29
CA2262252C (fr)	2006-01-10
ZA991220B (en)	2000-08-16
IS4975A (is)	1999-08-18
ID23218A (id)	2000-03-30
AR017723A1 (es)	2001-09-12
KR19990072616A (ko)	1999-09-27
TNSN99024A1 (fr)	2005-11-10
HUP9900386A3 (en)	1999-12-28
TR199900328A2 (xx)	1999-10-21
SG81261A1 (en)	2001-06-19
JPH11292766A (ja)	1999-10-26
AP9901464A0 (en)	1999-03-31
EP0951906A1 (fr)	1999-10-27
CN1231176A (zh)	1999-10-13
AU1732999A (en)	1999-09-02

Similar Documents

Publication	Publication Date	Title
NO990722L (no)	1999-08-18	Fremgangsmåte for behandling av hjertesvikt
MD970253A (ro)	1999-05-31	Inhibitori biciclici micromoleculari ai trombinei
UA66865C2 (uk)	2004-06-15	Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
LU91271I2 (fr)	2006-10-02	Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
MXPA03006855A (es)	2004-03-12	Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion.
WO2003057225A3 (fr)	2004-04-08	Inhibiteurs de transport du phosphate
DK0923570T3 (da)	2003-01-20	Pyridylalken- og pyridylalkynsyreamider som cytostatiske og immunosuppresive midler
DK1107794T3 (da)	2006-10-02	Terapeutiske præparater til behandling af mucus-hypersekretion
EA200401160A1 (ru)	2005-02-24	Производные тиазола и оксазола, которые модулируют активность ppar
BR9811099A (pt)	2002-05-14	Inibidores de urocinase
NO991206D0 (no)	1999-03-11	Benzamidinderivater substituert med sykliske aminosyre- eller sykliske hydroksysyrederivater, og deres anvendelse som antikoagulanter
ATE273279T1 (de)	2004-08-15	2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2
DK1066056T4 (da)	2009-04-14	Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
DK0888271T3 (da)	2004-08-16	Benzamidinderivater substitueret med aminosyre- og hydroxysyrederivater og deres anvendelse som antikoagulerende midler
EA200301276A1 (ru)	2004-04-29	Новые производные сульфоновых кислот
FI103111B1 (fi)	1999-04-30	Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi
AU8535182A (en)	1983-01-06	Pyridyl substituted pyridylalkyleneamino pyrimidones
DK0556322T3 (da)	1996-10-14	Aminosulfonylurinstof-ACAT-inhibitorer
NO993407L (no)	2000-01-11	Fremstilling av proteinpreparater med nedsatt aggregatinnhold
EA199800889A1 (ru)	1999-04-29	Способ предупреждения и/или лечения сердечной недостаточности и дисфункции желудочков антагонистами эндотелина, фармацевтическая композиция
ATE293602T1 (de)	2005-05-15	2-aminopyridine als inhibitoren von cyclooxygenase-2
DK1152760T3 (da)	2007-07-30	Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
NO20051390L (no)	2005-05-30	Fremgangsmate for behandling av pasienter med massivt blodtap
AU8438798A (en)	1999-01-04	Use of draflazine-analogues for treating pain
ES534452A0 (es)	1985-12-01	Un procedimiento para preparar un derivado de primidona